Moreover, EPCR+ sorted MDA-MB-231 human breast cancer cells showed stem cell-like properties and enhanced tumor-initiating activity, an effect inhibited by APC-EPCR blocking antibodies [18]. Here, PROCR is linked to breast carcinoma.